Cardax, Inc.
CDXI · OTC
3/31/2021 | 12/31/2020 | 9/30/2020 | 6/30/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.01 | 0.01 | -0.00 |
| FCF Yield | -18.91% | -29.64% | -18.03% | -25.59% |
| EV / EBITDA | -7.61 | -12.78 | -7.01 | -8.12 |
| Quality | ||||
| ROIC | 13.10% | 12.39% | 13.64% | 17.07% |
| Gross Margin | 63.30% | 65.79% | 58.62% | 71.10% |
| Cash Conversion Ratio | 0.24 | 0.39 | 0.30 | 0.26 |
| Growth | ||||
| Revenue 3-Year CAGR | -28.37% | -29.08% | -21.03% | -8.68% |
| Free Cash Flow Growth | 12.68% | 5.36% | 5.72% | 24.97% |
| Safety | ||||
| Net Debt / EBITDA | -5.70 | -10.03 | -4.56 | -5.66 |
| Interest Coverage | -1.76 | -1.29 | -1.68 | -0.79 |
| Efficiency | ||||
| Inventory Turnover | 0.04 | 0.07 | 0.03 | 0.04 |
| Cash Conversion Cycle | -2,186.37 | -344.42 | -1,966.08 | -1,124.85 |